Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 530 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Recruiting

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

NCT05914116

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +52 more
Locations
  • Research Site 111 Tucson, Arizona, United States
  • Research Site 125 Los Angeles, California, United States
  • Research Site 133 Los Angeles, California, United States
  • Research Site 103 Los Angeles, California, United States
View all 107 locations
View Trial Details
Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

NCT06915753

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +26 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center at Mount Zion San Francisco, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • The University of Kansas Medical Center Westwood, Kansas, United States
View all 16 locations
View Trial Details
Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations
  • Massive Bio SYNERGY-AI site Birmingham, Alabama, United States
  • Massive Bio SYNERGY-AI site Mobile, Alabama, United States
  • Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States
  • Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Recruiting

Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients

NCT05377034

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Beijing Tsinghua Changgung Hospital Beijing, China
  • People's Liberation Army General Hospital (1st and 6th Medical Centre) Beijing, China
  • West China Hospital, Sichuan University Chengdu, China
  • Shandong Cancer Hospital Jinan, China
View all 14 locations
View Trial Details

Related conditions